145 related articles for article (PubMed ID: 16140790)
21. Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women.
Corcoran A; Mahon BP; McParland P; Davoren A; Doyle S
J Med Virol; 2003 Jul; 70(3):475-80. PubMed ID: 12767014
[TBL] [Abstract][Full Text] [Related]
22. Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis.
Pongratz G; Lindner J; Modrow S; Schimanski S; Schölmerich J; Fleck M
J Intern Med; 2009 Sep; 266(3):296-301. PubMed ID: 19549095
[TBL] [Abstract][Full Text] [Related]
23. T lymphocyte responses against human parvovirus B19: small virus, big response.
Klenerman P; Tolfvenstam T; Price DA; Nixon DF; Broliden K; Oxenius A
Pathol Biol (Paris); 2002 Jun; 50(5):317-25. PubMed ID: 12116850
[TBL] [Abstract][Full Text] [Related]
24. Parvovirus B19 and the pathogenesis of anaemia.
Chisaka H; Morita E; Yaegashi N; Sugamura K
Rev Med Virol; 2003; 13(6):347-59. PubMed ID: 14625883
[TBL] [Abstract][Full Text] [Related]
25. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
[TBL] [Abstract][Full Text] [Related]
26. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
Ekman A; Hokynar K; Kakkola L; Kantola K; Hedman L; Bondén H; Gessner M; Aberham C; Norja P; Miettinen S; Hedman K; Söderlund-Venermo M
J Virol; 2007 Jul; 81(13):6927-35. PubMed ID: 17409158
[TBL] [Abstract][Full Text] [Related]
27. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
[TBL] [Abstract][Full Text] [Related]
28. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
[TBL] [Abstract][Full Text] [Related]
29. Serologic and molecular detection of human Parvovirus B19 infection.
Peterlana D; Puccetti A; Corrocher R; Lunardi C
Clin Chim Acta; 2006 Oct; 372(1-2):14-23. PubMed ID: 16765338
[TBL] [Abstract][Full Text] [Related]
30. Increased Numbers of CD4
Naciute M; Maciunaite G; Mieliauskaite D; Rugiene R; Zinkeviciene A; Mauricas M; Murovska M; Girkontaite I
In Vivo; 2017; 31(2):181-185. PubMed ID: 28358698
[TBL] [Abstract][Full Text] [Related]
31. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.
Li Y; Wang J; Zhu G; Zhang X; Zhai H; Zhang W; Wang W; Huang G
Am J Gastroenterol; 2007 Jul; 102(7):1489-98. PubMed ID: 17459020
[TBL] [Abstract][Full Text] [Related]
32. Unscrambling the role of human parvovirus B19 signaling in systemic autoimmunity.
Tsay GJ; Zouali M
Biochem Pharmacol; 2006 Nov; 72(11):1453-9. PubMed ID: 16764828
[TBL] [Abstract][Full Text] [Related]
33. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Tsai CC; Chiu CC; Shi JY; Hsu TC
Clin Chim Acta; 2008 Sep; 395(1-2):77-83. PubMed ID: 18538665
[TBL] [Abstract][Full Text] [Related]
35. Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases.
Tomasini D; Tomasini CF; Cerri A; Sangalli G; Palmedo G; Hantschke M; Kutzner H
J Cutan Pathol; 2004 Sep; 31(8):531-8. PubMed ID: 15268707
[TBL] [Abstract][Full Text] [Related]
36. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
37. Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.
Tolfvenstam T; Oxenius A; Price DA; Shacklett BL; Spiegel HM; Hedman K; Norbeck O; Levi M; Olsen K; Kantzanou M; Nixon DF; Broliden K; Klenerman P
J Virol; 2001 Jan; 75(1):540-3. PubMed ID: 11119624
[TBL] [Abstract][Full Text] [Related]
38. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
39. CD8(+) T-cell responses to adeno-associated virus capsid in humans.
Mingozzi F; Maus MV; Hui DJ; Sabatino DE; Murphy SL; Rasko JE; Ragni MV; Manno CS; Sommer J; Jiang H; Pierce GF; Ertl HC; High KA
Nat Med; 2007 Apr; 13(4):419-22. PubMed ID: 17369837
[TBL] [Abstract][Full Text] [Related]
40. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
